Journal ArticleOPEN ACCESS

Recent Advances with Topotecan in the Treatment of Lung Cancer

  • O'Brien M
  • Eckardt J
  • Ramlau R
The Oncologist (2007) 12(10) 1194-1204
DOI: 10.1634/theoncologist.12-10-1194
45Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

After completing this course, the reader will be able to: Describe phase I studies evaluating the pharmacokinetics and early safety data of single-agent oral topotecan.Discuss the results and implications of clinical trials evaluating oral topotecan for small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC).Explain why topotecan is a good candidate for combination with other novel anticancer agents.Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com

Cite

CITATION STYLE

APA

O’Brien, M., Eckardt, J., & Ramlau, R. (2007). Recent Advances with Topotecan in the Treatment of Lung Cancer. The Oncologist, 12(10), 1194–1204. https://doi.org/10.1634/theoncologist.12-10-1194

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free